Axis Bank- Growth outlook strong; a robust 18% core PPoP growth from FY23 to FY26F seen
时间:2024-06-26 06:55:24 阅读(143)
Axis reported a profit after tax (PAT) of Rs 58 billion in Q1FY24, showing a 41% year-on-year increase. The PAT was 9% below our estimate but in line with Bloomberg consensus. The PAT miss was attributed to softened topline growth and core fees, resulting in a 7% deviation from our core pre-provision operating profit (PPoP) estimate. This quarter marked the first full reporting period for Axis Bank since the acquisition of Citibank (unlisted), leading to some discrepancies compared to estimates, which were expected.
Our analysis suggests a decline in Citi’s fee line compared to the annualised run-rate of CY20 (last disclosed by AXSB before the acquisition), indicating some softness. Consequently, we have adjusted our FY24-26F EPS by 2%. Axis Bank’s RoA decreased to 1.8% in 1Q from 2.1% in 4Q, due to higher operating expenses related to Citi’s integration and credit costs, as well as lower NIMs. Excluding the impact of integration costs (expected to continue until 2QFY25F), the RoA in 1Q was at 1.9%.
Loan growth recorded a solid 22% y-o-y increase, with retail, corporate, and SME segments growing at rates of 21%, 25%, and 24% y-o-y, respectively. However, on a sequential basis, the growth was subdued, with only a 2% q-o-q increase, primarily due to softer trends in home loans and LAP (loan against property) segments.
As for deposits, there was a notable 17% y-o-y growth, but there was a slight decline of 1% q-o-q. The decline in current account deposits by 10% q-o-q is seasonal in nature and contributed to the overall q-o-q decrease in deposits. On a quarterly average basis, Axis Bank’s deposits saw a healthy growth of 6% q-q.
CASA ratio improved to 45.5%, representing a significant y-o-y increase of 180 bps. NIMs experienced a q-o-q decline of 12 bps, which aligned with ICICI Bank’s performance. Core PPoP reached Rs 83 billion, showing a noteworthy 27% y-y growth but a decline of 9% q-q. The core-PPoP fell 7% below our estimates due to lower net interest income (NII) and fee income. Asset quality remained stable, with gross non-performing loans slightly declining to 2.1% compared to the previous quarter’s 2.2%.
Valuation and viewWe assign a valuation of 1.9x Jun-2025F BVPS (book value per share) to the core-bank, and the subsidiaries are valued at Rs 44 per share. Axis Bank remains one of our top choices among banks, and we maintain a positive outlook on the stock.
上一篇:Buy Paytm and Whirlpool shares for near-term gains as Nifty enters up-trend, index may head to 16557
下一篇:Year-ahead -Top realtors expect 10-15% jump in home sales
猜你喜欢
- Bulls may stage a comeback, Nifty to head towards 17820 above 17700; 5 things to know before opening bell
- Blood all over! Tesla robot rips engineer’s back with metal claws at Texas plant
- s, especially those with taste changes or dietary limits, to stick with the treatment. In a nutshell, BDENZA ORAL SOLUTION is a simpler, more patient-friendly way to tackle prostate cancer. It can help improving the patient compliance to a great extent,” Dr. Aravind Badiger Director, Technical Formulation said in a statement.
BDENZA ORAL SOLUTION represents a significant advancement in prostate cancer therapy, offering relief and hope to millions of patients worldwide.
“BDENZA represents a paradigm shift in prostate cancer therapy. Its introduction aligns with our relentless pursuit to provide accessible and patient-centric healthcare solutions. This first-of-its-kind oral solution that addresses the challenges faced by many patients, offering convenience, reduced side effects, and a palatable sugar-free taste and affordability,” Raheel Shah, BDR Group Director (Business Development) said in a statement.
- Bhopal’s Raja Bhoj International Airport granted Immigration Check Post status, here’s what it means
- Rupee falls 9 paise to close at 81
- Stocks To Watch- Wipro, Patanjali Foods, Federal Bank, RVNL, Bandhan Bank, CSB Bank, DLF
- Talbros to divest 40% stake for Rs 81
- Stocks waver, dollar softens as investors weigh earnings, data
- Bharti Airtel share price falls as Reliance Jio launches cheaper plans; HSBC says ‘no threat’, rates ‘Buy’